Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Reporting of Adverse Events in Published and Unpublished Studies of Health Care Interventions: A Systematic Review.

Golder S, Loke YK, Wright K, Norman G.

PLoS Med. 2016 Sep 20;13(9):e1002127. doi: 10.1371/journal.pmed.1002127.

2.

Antiepileptic drugs' tolerability and safety--a systematic review and meta-analysis of adverse effects in dogs.

Charalambous M, Shivapour SK, Brodbelt DC, Volk HA.

BMC Vet Res. 2016 May 21;12:79. doi: 10.1186/s12917-016-0703-y. Review.

3.

Case reports published by residents of Texas Tech University Health Sciences Center, Lubbock, 2008-2013.

Buscemi D, Argueta E, Nugent K.

Proc (Bayl Univ Med Cent). 2014 Oct;27(4):313-4.

4.

Comprehensive evaluations of the adverse effects of drugs: importance of appropriate study selection and data sources.

Loke YK, Golder SP, Vandenbroucke JP.

Ther Adv Drug Saf. 2011 Apr;2(2):59-68. doi: 10.1177/2042098611401129. Review.

5.

Acupuncture for the treatment of urinary incontinence: A review of randomized controlled trials.

Paik SH, Han SR, Kwon OJ, Ahn YM, Lee BC, Ahn SY.

Exp Ther Med. 2013 Sep;6(3):773-780.

6.

Comparison of pooled risk estimates for adverse effects from different observational study designs: methodological overview.

Golder S, Loke YK, Bland M.

PLoS One. 2013 Aug 20;8(8):e71813. doi: 10.1371/journal.pone.0071813. Review.

7.
8.

Drug safety assessment in clinical trials: methodological challenges and opportunities.

Singh S, Loke YK.

Trials. 2012 Aug 20;13:138. doi: 10.1186/1745-6215-13-138. Review.

9.

Meta-analyses of adverse effects data derived from randomised controlled trials as compared to observational studies: methodological overview.

Golder S, Loke YK, Bland M.

PLoS Med. 2011 May;8(5):e1001026. doi: 10.1371/journal.pmed.1001026. Review.

10.

Improving reporting of adverse drug reactions: Systematic review.

Molokhia M, Tanna S, Bell D.

Clin Epidemiol. 2009 Aug 9;1:75-92.

11.

Information about ADRs explored by pharmacovigilance approaches: a qualitative review of studies on antibiotics, SSRIs and NSAIDs.

Aagaard L, Hansen EH.

BMC Clin Pharmacol. 2009 Mar 3;9:4. doi: 10.1186/1472-6904-9-4. Review.

12.

Systematic reviews of adverse effects: framework for a structured approach.

Loke YK, Price D, Herxheimer A; Cochrane Adverse Effects Methods Group..

BMC Med Res Methodol. 2007 Jul 5;7:32. Review.

13.

What is the best evidence for determining harms of medical treatment?

Vandenbroucke JP.

CMAJ. 2006 Feb 28;174(5):645-6. No abstract available.

14.

Case reports of suspected adverse drug reactions--systematic literature survey of follow-up.

Loke YK, Price D, Derry S, Aronson JK.

BMJ. 2006 Feb 11;332(7537):335-9. Review.

15.

Metameta-analysis.

Aronson JK.

Br J Clin Pharmacol. 2005 Aug;60(2):117-9. No abstract available.

16.

Benefits and harms of drug treatments.

Vandenbroucke JP.

BMJ. 2004 Jul 3;329(7456):2-3. No abstract available.

Items per page

Supplemental Content

Support Center